TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
INVA

Innoviva Inc

Healthcare · Biotechnology

21.10$ -0.7% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Innoviva Inc (INVA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 93.6% of the shares are freely tradable; institutional investors hold 108.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 108.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 93.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 13.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 72Mio.

Largest Shareholders

Institutions

Institutions INVA
Name Stake (%) Shares Change (%) Date
BlackRock Inc 15.65 11,307,845 +5.9 03/31/2026
Dimensional Fund Advisors, Inc. 6.22 4,494,053 +1.3 06/30/2026
Vanguard Portfolio Management, LLC 5.85 4,224,951 +0.0 03/31/2026
Renaissance Technologies Corp 5.61 4,055,632 -3.7 03/31/2026
Vanguard Capital Management, LLC 4.35 3,141,581 +0.0 03/31/2026
State Street Corp 4.24 3,060,377 +9.4 03/31/2026
Millennium Management LLC 3.52 2,541,109 +11.5 06/30/2026
Systematic Financial Management LP 2.80 2,024,082 -4.3 03/31/2026

Funds

Funds INVA
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 5.91 4,271,680 +0.0 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.09 2,231,526 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings INVA
Person Role Shares Value As of Type
Raifeld Pavel Chief Executive Officer 284,799 6,009,259 $ Aug 20, 2026 direct
Basso Stephen Chief Financial Officer 88,013 1,857,074 $ Aug 20, 2026 direct
Zhen Marianne Chief Accounting Officer 56,389 1,189,808 $ Aug 20, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 20, 2026 Zhen Marianne Chief Accounting Officer Other 1,127 21.00 23,667
Aug 20, 2026 Basso Stephen Chief Financial Officer Other 558 21.00 11,718
Aug 20, 2026 Raifeld Pavel Chief Executive Officer Other 1,130 21.00 23,730

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?